Xvivo Perfusion AB (XVIVO) — Cash Flow Reinvestment Rate

Latest as of March 2026: 0.00x

Xvivo Perfusion AB (XVIVO) has a Cash Flow Reinvestment Rate of 0.00x as of March 2026, reinvesting Skr0.00 (capex Skr0.00 ) from operating cash flow of Skr65.34 Million. Explore Xvivo Perfusion AB capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

Skr0.00
Capex + Investments

Operating Cash Flow

Skr65.34 Million
SEK

Capital Expenditures

Skr0.00
SEK

Xvivo Perfusion AB Cash Flow Reinvestment Rate (2011–2025)

Historical reinvestment intensity for Xvivo Perfusion AB across 12 annual periods. Also explore XVIVO total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Xvivo Perfusion AB (2011–2025)

Year-by-year capital reinvestment analysis for Xvivo Perfusion AB. For live market cap and broader valuation context, see Xvivo Perfusion AB stock valuation.

Year Reinvestment Rate Total Reinvested (SEK) Operating CF Capex YoY Change
2025 1.00x Skr101.14 Million Skr101.07 Million Skr101.07 Million ▼ -74.5%
2024 3.93x Skr436.97 Million Skr111.29 Million Skr193.15 Million ▼ -20.7%
2023 4.95x Skr229.10 Million Skr46.29 Million Skr43.02 Million ▼ -58.0%
2022 11.80x Skr328.57 Million Skr27.86 Million Skr130.95 Million ▲ +315.1%
2019 2.84x Skr83.84 Million Skr29.50 Million Skr83.69 Million ▲ +22.4%
2018 2.32x Skr54.86 Million Skr23.63 Million Skr54.71 Million ▲ +47.2%
2017 1.58x Skr35.01 Million Skr22.19 Million Skr34.93 Million ▼ -60.6%
2016 4.00x Skr50.24 Million Skr12.55 Million Skr20.51 Million ▲ +140.3%
2015 1.67x Skr14.29 Million Skr8.58 Million Skr13.21 Million ▲ +72.8%
2013 0.96x Skr12.98 Million Skr13.46 Million Skr12.59 Million ▼ -45.6%
2012 1.77x Skr2.96 Million Skr1.67 Million Skr2.96 Million ▲ +96549.9%
2011 0.00x Skr26.00K Skr14.17 Million Skr26.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow